91 related articles for article (PubMed ID: 2562645)
1. Potential therapeutic value of muramyl peptides for modulating human immunologic responses.
Fogler WE
Biotechnol Ther; 1989-1990; 1(1):69-83. PubMed ID: 2562645
[TBL] [Abstract][Full Text] [Related]
2. [The immunostimulating activity of muramyl dipeptide and its derivatives].
Karsonova MI; Andronova TM; Pinegin BV; Khaitov RM
Zh Mikrobiol Epidemiol Immunobiol; 1999; (3):104-10. PubMed ID: 10852007
[No Abstract] [Full Text] [Related]
3. Influence of synthetic adjuvants on nonspecific resistance to infections.
Parant M
Int J Immunopharmacol; 1994; 16(5-6):445-9. PubMed ID: 7927991
[TBL] [Abstract][Full Text] [Related]
4. The rediscovery of host defense enhancement.
Polk HC
J Thorac Cardiovasc Surg; 1984 Nov; 88(5 Pt 2):867-71. PubMed ID: 6492852
[TBL] [Abstract][Full Text] [Related]
5. Immunopharmacology of muramyl peptides.
Masek K
Fed Proc; 1986 Oct; 45(11):2549-51. PubMed ID: 3758372
[TBL] [Abstract][Full Text] [Related]
6. Muramyl peptides: immunomodulators, sleep factors, and vitamins.
Adam A; Lederer E
Med Res Rev; 1984; 4(2):111-52. PubMed ID: 6374337
[No Abstract] [Full Text] [Related]
7. [Use of muramyl dipeptides in models of synthetic vaccines].
Audibert F
Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulation of macrophages by muramyl peptides: recent findings concerning somnogenic activity of muramyl peptides and monokine.
Leclerc C; Chedid L
Int J Tissue React; 1984; 6(3):215-8. PubMed ID: 6332794
[TBL] [Abstract][Full Text] [Related]
9. [Immunoactive peptides].
Ivanov VT
Vopr Med Khim; 1984; 30(3):23-31. PubMed ID: 6206648
[TBL] [Abstract][Full Text] [Related]
10. Potential use of muramyl peptides in cancer therapy.
Chedid LA
Prog Clin Biol Res; 1983; 132E():261-71. PubMed ID: 6359172
[No Abstract] [Full Text] [Related]
11. [Antimetastatic effect of a liposome-entrapped synthetic analog of muramyl dipeptide].
Umanskiĭ VIu; Stefanov AV; Los' GV; Andronova TM; Balitskiĭ KP
Dokl Akad Nauk SSSR; 1986; 286(2):474-6. PubMed ID: 3004870
[No Abstract] [Full Text] [Related]
12. [Stimulation of the nonspecific resistance by beta-heptylglycoside-muramyldipeptide in mice].
Kaliuzhin OV; Kaliuzhin VV; Zemliakov AE; Elkina SI; Shkalev MV; Sergeev VV
Biull Eksp Biol Med; 1999 May; 127(5):543-5. PubMed ID: 10399577
[No Abstract] [Full Text] [Related]
13. [Immunopharmacological activities of bacterial cell walls and related synthetic compounds (muramyl peptides)].
Kotani S; Takada H
Yakugaku Zasshi; 1983 Jan; 103(1):1-27. PubMed ID: 6191019
[No Abstract] [Full Text] [Related]
14. [Muramyl peptides and their pharmacological properties].
Kołodziejczyk AM; Kołodziejczyk AS
Postepy Biochem; 1987; 33(2-3):203-29. PubMed ID: 3330226
[No Abstract] [Full Text] [Related]
15. Immunological activities of muramyl peptides.
Bahr GM; Chedid L
Fed Proc; 1986 Oct; 45(11):2541-4. PubMed ID: 3489642
[TBL] [Abstract][Full Text] [Related]
16. Synthetic muramyl peptides: their origin, present status, and future prospects. Introductory remarks.
Chedid L
Fed Proc; 1986 Oct; 45(11):2531-3. PubMed ID: 3758370
[No Abstract] [Full Text] [Related]
17. Effect of muramyl peptides and tumor necrosis factor on oxidative responses of human blood phagocytes.
Jupin C; Parant M; Chedid L
Immunol Lett; 1989 Sep; 22(3):187-92. PubMed ID: 2553589
[TBL] [Abstract][Full Text] [Related]
18. Role of muramyl peptides for the enhancement of synthetic vaccines.
Chedid L; Audibert F; Jolivet M
Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
[TBL] [Abstract][Full Text] [Related]
19. The activation of human monocytes by liposome-encapsulated muramyl dipeptide analogues.
Lopez-Berestein G; Mehta K; Mehta R; Juliano RL; Hersh EM
J Immunol; 1983 Apr; 130(4):1500-2. PubMed ID: 6300230
[No Abstract] [Full Text] [Related]
20. Enhancement of the effectiveness of antimicrobial therapy by muramyl peptide immunomodulators.
O'Reilly T; Zak O
Clin Infect Dis; 1992 May; 14(5):1100-9. PubMed ID: 1600012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]